For general questions: Reply to this tweet
For personal treatment questions: DM me —be brief
#myelomaVR #mmsm @mtmdphd @NorthTxMSG @MyelomaTeacher @grpetersen1 @IMFjimMYELOMA
Thread
Any myeloma colleagues willing to help out with this thread, please chime in and give your input also. @SagarLonialMD @szusmani @myelomaMD
2/ Question: Should we stop Revlimid maintenance to lower risk of COVID?
Answer: Dont stop maintenance. Relapse of myeloma is riskier than Revlimid
Answer: Risk is low with plerixafor. Risk of exposing patients to COVID during collection is far more than risk of not being able to collect. Delay collection for now
Answer: VRd x 8. Len maintenance (for most patients). If high risk Len plus bortezomib (lower dose than initial VRd). @NorthTxMSG @mtmdphd
Answer: Slow and steady wins the race. A slow response does not mean that the disease is bad. Risk of transplant is high. So continue on treatment that’s working.
Answer: No
Answer: My colleagues and I feel we have no data but that a short interruption till one recovers from COVID seems prudent. No data.
Answer: No. please let’s do Zometa every 3-4 months. I was not convinced of the need for monthly before. And I’m even more convinced of that now in light of the COVID situation.